| 000 | 01688 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514215059.0 | ||
| 264 | 0 | _c20050620 | |
| 008 | 200506s 0 0 eng d | ||
| 022 | _a0105-4538 | ||
| 024 | 7 |
_a10.1111/j.1398-9995.2005.00703.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKrug, N | |
| 245 | 0 | 0 |
_aEffect of loteprednol etabonate nasal spray suspension on seasonal allergic rhinitis assessed by allergen challenge in an environmental exposure unit. _h[electronic resource] |
| 260 |
_bAllergy _cMar 2005 |
||
| 300 |
_a354-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Intranasal |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAerosols |
| 650 | 0 | 4 |
_aAllergens _ximmunology |
| 650 | 0 | 4 |
_aAndrostadienes _xadministration & dosage |
| 650 | 0 | 4 |
_aAnti-Allergic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aEnvironmental Exposure |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLoteprednol Etabonate |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aRhinitis, Allergic, Seasonal _xdrug therapy |
| 650 | 0 | 4 | _aSuspensions |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aHohlfeld, J M | |
| 700 | 1 | _aGeldmacher, H | |
| 700 | 1 | _aLarbig, M | |
| 700 | 1 | _aHeermann, R | |
| 700 | 1 | _aLavallee, N | |
| 700 | 1 | _aNguyen, D T | |
| 700 | 1 | _aPetzold, U | |
| 700 | 1 | _aHermann, R | |
| 773 | 0 |
_tAllergy _gvol. 60 _gno. 3 _gp. 354-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1398-9995.2005.00703.x _zAvailable from publisher's website |
| 999 |
_c15357448 _d15357448 |
||